Skip to main content

Table 1 Patients’ baseline characteristics

From: A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia

Patient

Age

Sex

Underlying disease

Platelet count (103/μL)

Bleeding scale

Sites and duration

Reason for transfusion

1

84

F

Microscopic polyangitis

25

1

Soft tissue, temporal

Prophylactic

2

36

M

SLE

58

3

Oral cavity, persistent

Bleeding tendency

3

52

F

TAFRO syndrome

43

0

None

Before the invasive procedure

4

70

F

Acute liver failure

27

2

Soft tissue, temporal

Bleeding tendency

5

65

M

Alcoholic hepatitis

11

4

GI tract, persistent

Bleeding tendency

6

44

F

Acute pancreatitis

53

1

Soft tissue, temporal

Prophylactic

7

76

M

Sepsis

16

2

Urinary, temporal

Bleeding tendency

8

84

M

SFTS

38

2

Soft tissue, persistent

Bleeding tendency

9

28

M

AML

13

3

Trachea, persistent

Bleeding tendency

10

73

M

Liver abscess

38

0

None

Before the invasive procedure

  1. F female; M male; SLE systemic lupus erythematosus; TAFRO thrombocytopenia, anasarca, myelofibrosis, renal dysfunction, and organomegaly; SFTS severe fever with thrombocytopenia syndrome; AML acute myeloid leukemia; GI gastrointestinal